|
Year
|
Lecturer
|
Topic
|
Institution
|
| 1972 |
David A. Price Evans
|
The Ecology of Drug
Therapy |
U. of Liverpool, England |
| 1973 |
Eugene Braunwald |
Protection of the
Ischemic Myocardium |
Peter Brent Brigham
Hospital |
| 1974 |
John Laragh |
The Renin System in
the Understanding and Treatment of Hypertension |
Columbia U. |
| 1975 |
Attallah Kappas |
Steriod Studies in
Experimental and Human Hepatic Porphyria |
The Rockefeller U. |
| 1976 |
Kenneth L. Melmon |
Inflammatory &
Immune Responses Cell Individuality Amidst Ubiquitous
Hormonal Signals |
U.of California, San
Francisco |
| 1977 |
John A. Oates |
The Prostaglandin-Thromboxane
System: Pathophysiologic & Pharmacologic Implications |
Vanderbilt U. |
| 1978 |
Daniel L. Azarnoff |
Alterations in Drug
Therapy Required by Disease States |
U. of Kansas Medical
Center |
| 1979 |
Thomas W. Smith |
Digitalis Glycosides:
Basic Mechanisms and Clinical Implications |
Harvard Medical School |
| 1980 |
Peter Goldman |
Metronidazole (Flagyl):
Benefit Versus Risk |
Harvard Medical School |
| 1981 |
W. Leigh Thompson,
Jr. |
Pharmacologic Principles
in the Management of Poisonings |
Case Western U. |
| 1982 |
Thomas Merigan, Jr. |
Interferon as a Therapeutic
Agent in Man |
Stanford U. SOM |
| 1983 |
Leon Goldberg |
Dopamine: Fundamental
Discoveries from Clinical Investigations |
U. of Chicago |
| 1984 |
Richard Weinshilboum |
Pharmacogenetics of
Drug Metabolism in Man |
Mayo Clinic |
| 1985 |
Jerry Mitchell |
Glutathione, Calcium,
and Chemical-Induced Injury |
Baylor College of
Medicine |
| 1986 |
Folke Sjoqvist |
Interindividual Differences
in Drug Metabolism and Their Clinical Implications |
Huddinge U. Hospital,
Sweden |
| 1987 |
Henry Bourne |
Diseases of Transmembrane
Signalling: Altered G Proteins |
U. of California,
San Francisco |
| 1988 |
Anthony Cerami |
Cachectin-TNF: A Macrophage
Protein that Induces a Catabolic State and Shock |
The Rockefeller U. |
| 1989 |
Sir James Black |
Gastric Histamine:
From Dale to Date |
King's College Hospital,
SOM, London |
| 1990 |
Gertrude Elion |
The Purine Path to
Chemotherapy |
Burroughs Wellcome
Co. |
| 1991 |
James Ritter |
Clinical Pharmacology
of Endothelium Derived Mediators |
Guy's Hospital, U.
of London |
| 1992 |
Louis Lasagna |
Optimizing Pharmacotherapy
- The Never Ending Challenge |
Tufts U. |
| 1995 |
Carl C. Peck |
Drug Development:
The Way It Could Be |
Georgetown U. Medical
Center |
| 1996 |
Gary J. Nabel |
Human Gene Therapy:
Present and Future Prospects |
U. of Michigan |
| 1998 |
Erik De Clercq |
Antiviral Drug Discovery
and Development
|
Katholieke U. Leeuven,
Belgium |
| 2000 |
Ferid Murad
|
Cellular Signaling
with Nitric Oxide and Cyclic GMP |
U. of Texas, Houston |
| 2001 |
Raymond Woosley |
Role of Biologic Sex
in Drug-Induced Arrhythmias |
Georgetown U. Medical
Center |
| 2002 |
Philip Needleman |
COX-2 Inhibitors:
From Inflammation to Cancer |
Pharmacia Corporation |
